Pharmacy major Walgreens Boot Alliance Inc. reported Thursday a hefty loss in its first quarter, mainly hit by charges related to opioid-related claims and weak sales. Adjusted earnings, and sales, however, topped market estimates mainly benefited by strong cough, cold, flu sales. Looking ahead, the company maintained its fiscal 2023 earnings view, and raised sales guidance.
from RTT - Top Story https://ift.tt/Qrsf9vA
via IFTTT
from RTT - Top Story https://ift.tt/Qrsf9vA
via IFTTT
Comments
Post a Comment